Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
SIM-0610 in Hepatocellular Carcinoma: NCT07348211 Clinical Landscape Report 2026
16 October 2026
NCT07348211 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Mesalamine in Colitis, Ulcerative: NCT07349472 Clinical Landscape Report 2026
16 October 2026
NCT07349472 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dronabinol in Parkinson Disease: NCT07346690 Clinical Landscape Report 2026
16 October 2026
NCT07346690 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
![[18F]MK-0947 in Parkinson Disease: NCT07348250 Clinical Landscape Report 2026](https://synapse-static.patsnap.com/strapi-static/Blog_cover_02_0815c5db75.jpg)
9 min read
[18F]MK-0947 in Parkinson Disease: NCT07348250 Clinical Landscape Report 2026
16 October 2026
NCT07348250 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tislelizumab in Lymphatic Metastasis: NCT07353294 Clinical Landscape Report 2026
16 October 2026
NCT07353294 clinical landscape for Lymphatic Metastasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Apatinib Mesylate in stomach adenocarcinoma: NCT07353684 Clinical Landscape Report 2026
16 October 2026
NCT07353684 clinical landscape for stomach adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tislelizumab in Advanced Pancreatic Ductal Adenocarcinoma: NCT07348107 Clinical Landscape Report 2026
16 October 2026
NCT07348107 clinical landscape for Advanced Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development w…
9 min read
Cizutamig in Colitis, Ulcerative: NCT07353450 Clinical Landscape Report 2026
16 October 2026
NCT07353450 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
68Ga-XH06 in Hepatocellular Carcinoma: NCT07352345 Clinical Landscape Report 2026
16 October 2026
NCT07352345 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Autologous Tumor-reactive T Cells(GK-01)(Geek Gene Technology) in Solid tumor: NCT07351903 Clinical Landscape Report 2026
16 October 2026
NCT07351903 clinical landscape for Solid tumor: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
REGEND007 in Pulmonary Disease, Chronic Obstructive: NCT07355868 Clinical Landscape Report 2026
16 October 2026
NCT07355868 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
JKN2403 in Pulmonary Disease, Chronic Obstructive: NCT07351734 Clinical Landscape Report 2026
16 October 2026
NCT07351734 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…